Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

26
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
26
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

136
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
136
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

28
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between aortic wall thrombus and stroke among patients undergoing transfemoral aortic valve replacement.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

The burden and outcomes of vaccine-preventable infections among adult congenital heart disease patients: a nationwide analysis.

Proceedings (Baylor University. Medical Center)·2026
Same author

The Impact of COVID-19 Infection and Vaccination on Myocarditis Incidence: A Comparative Analysis of Pre-, Peri-, and Post-Pandemic Eras.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Fluoroscopy-Free Pulsed Field Ablation for Atrial Fibrillation: A Systematic Review of Procedural Feasibility and Safety.

Pacing and clinical electrophysiology : PACE·2026
Same author

Scaling what works: a collaborative capacity-building program tailored to optimize resources and scale evidence-based interventions for cancer prevention and control.

Cancer causes & control : CCC·2026
Same author

Saphenous vein graft longevity: Novel approaches.

Cardiovascular revascularization medicine : including molecular interventions·2026

Related Experiment Video

Updated: Sep 6, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Implementation of Multiple Evidence-Based Heart Failure Therapies.

Azka Latif1, Muhammad Junaid Ahsan2, Noman Lateef3

  • 1Creighton University School of Medicine, Omaha, NE.

Current Problems in Cardiology
|June 26, 2022
PubMed
Summary

Acute heart failure remains a major cause of death and illness. This review explores barriers to implementing guideline-directed therapies and proposes solutions to improve patient outcomes and reduce healthcare costs.

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

868

Related Experiment Videos

Last Updated: Sep 6, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

868

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Health Services Research

Background:

  • Acute heart failure (AHF) is a leading cause of mortality and morbidity despite medical advancements.
  • AHF hospitalizations impose a significant financial burden on healthcare systems.
  • Improving AHF care quality and outcomes remains a critical research and policy focus.

Purpose of the Study:

  • To review guideline-directed therapies for heart failure.
  • To identify challenges hindering the widespread adoption of these therapies.
  • To propose potential solutions to overcome these barriers and improve patient outcomes.

Main Methods:

  • Literature review of current guidelines and clinical trial data.
  • Analysis of barriers to therapy implementation (physician, patient, economic, systemic, logistical).
  • Synthesis of potential strategies to enhance therapeutic adherence and effectiveness.

Main Results:

  • Despite established guidelines, significant barriers impede optimal heart failure management.
  • These barriers encompass physician-related, patient-related, economic, healthcare system, and logistical factors.
  • Effective implementation requires addressing these multifaceted challenges.

Conclusions:

  • Overcoming implementation barriers is crucial for reducing heart failure mortality and morbidity.
  • Targeted solutions are needed to bridge the gap between guidelines and clinical practice.
  • Improving heart failure outcomes necessitates a comprehensive approach addressing systemic and individual-level factors.